A biochemical and structural analysis of genetic diversity within the HLA-A*11 subtype

Immunogenetics

Volumn 57, Issue 5, 2005, Pages 315-325

  Li, Lenong ^a   Chen, Weifeng ^a   Bouvier, Marlene ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

11 alleles; Alloreactivity; Antigen selection and presentation; HLA A; Natural polymorphism; Structural analysis

Indexed keywords

HLA A 11 ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ALPHA HELIX; ANTIGEN PRESENTATION; ANTIGEN STRUCTURE; ARTICLE; CRYSTAL STRUCTURE; CYTOTOXIC T LYMPHOCYTE; DNA POLYMORPHISM; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; MOLECULAR MODEL; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN BINDING; STRUCTURE ANALYSIS; THERMOSTABILITY;

BINDING SITES; HLA-A ANTIGENS; HUMANS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; TEMPERATURE; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 21344470461     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-005-0801-7     Document Type: Article

References (73)

1. Bettinotti MP, Mitsuishi Y, Lau M, Silver H, Spence A, Terasaki PI (1996) HLA-A*1104: a new allele found in a Laotian family. Tissue Antigens 48:717-719
2. Bhatia K, Richens J, Prasad ML, Koki G (1988) High prevalence of the haplotype HLA-A11, B27 in arthritis patients from the highlands of Papua New Guinea. Tissue Antigens 31:103-106
3. Bouvier M, Wiley DC (1994) Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265:398-402
4. 2m heterodimer. Nat Struct Biol 5:377-384
5. Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, Robb ML, Rinkaew M, Birx DL, Khamboonruang C, Zimmerman PA, Nelson KE, Natpratan C (1999) Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. J Infect Dis 179:59-67
6. Carson M (1997) Ribbons. Methods Enzymol 277:493-505
7. Celis E, Fikes J, Wentworth P, Sidney J, Southwood S, Maewal A, del Guercio MF, Sette A, Livingston B (1994) Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Mol Immunol 31:1423-1430
8. Cheung W, Ren E-C, Chan S-H, Gong W-K, Yap H-K (2002) Increased HLA-A*11 in Chinese children with steroid-responsive nephrotic syndrome. Pediatr Nephrol 17:212-216
9. Cowan EP, Jelachich ML, Coligan JE, Biddison WE (1987) Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major histocompatibility complex-restricted and alloreactive cytotoxic T-lymphocyte recognition. Proc Natl Acad Sci U S A 84:5014-5018
10. Culmann-Penciolelli B, Lamhamedi-Cherradi S, Couillin I, Guegan N, Levy JP, Guillet JG, Gomard E (1994) Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein. J Virol 68:7336-7343
11. Del Guercio M-F, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A (1995) Binding of a peptide antigen to multiple HLA alleles allows definition of an HLA-A2 like supertype. J Immunol 154:685-693
12. DiBrino M, Parker KC, Shiloach J, Knierman M, Lukszo J, Turner RV, Biddison WE, Coligan JE (1993) Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permits identification of potential antigenic peptides. Proc Natl Acad Sci U S A 90:1508-1512
13. Domenech N, Henderson RA, Finn OJ (1995) Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J Immunol 155:4766-4774
14. Evans SV (1993) SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J Mol Graphics 11:134-138
15. Falk K, Rotzschke O, Takiguchi M, Grahovac B, Gnau V, Stevanovic S, Jung G, Rammensee H-G (1994) Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40:238-241
16. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY (1990) Bone-marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 323: 1818-1822
17. Fleischhauer K, Avila D, Vilbois F, Traversari C, Bordignon C, Wallny H-J (1994) Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens 44:311-317
18. Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A 89:3429-3433
19. Garcia-Peydro M, Paradela A, Lamas JR, Lopez de Castro JA (1999) Peptide presentation to an alloreactive CTL clone is modulated through multiple mechanisms involving polymorphic and conserved residues in HLA-B27. J Immunol 163:6060-6064
20. Garino E, Belvedere M, Berrino M, Bertola L, Dall'Omo AM, Mazzola G, Rossetto C, Carcassi C, Lai S, Gay E, Ricotti M, Curtoni ES (2002) New HLA-A*11 allele, A*1112, identified by sequence-based typing. Tissue Antigens 60:84-87
21. Gavioli R, DeCampos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG (1992) Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proc Natl Acad Sci U S A 89:5862-5866
22. Guo H-C, Jardetzky TS, Garrett TPJ, Lane WS, Strominger JL, Wiley DC (1992) Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360:364-366
23. Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, Rowland-Jones S, Braud VM (2004) Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34:1673-1679
24. Herman J, Jongeneel V, Kuznetsov D, Coulie PG (1999) Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid. Tissue Antigens 53:111-121
25. Hogan KT, Clayberger C, Bernhard EJ, Walk SF, Ridge JP, Parham P, Krensky AM, Engelhard VH (1988) Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3. J Immunol 141:2519-2525
26. Jones TA, Zou J-Y, Cowan SW, Kjeldgaard M (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A47:110-119
27. Kast WM, Brandt RMP, Sidney J, Drijfhout J-W, Kubo RT, Grey HM, Melief CJM, Sette A (1994) Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol 152:3904-3912
28. Kawashima I, Tsai V, Southwood S, Takesako K, Sette A, Celis E (1999) Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells. Cancer Res 59:431-435
29. Kjer-Nielsen L, Clements CS, Brooks AG, Purcell AW, Fontes MR, McCluskey J, Rossjohn J (2002) The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J Immunol 169:5153-5160
30. Krangel MS, Biddison WE, Strominger JL (1983) Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes. II. Variant DK1: evidence for a discrete CTL recognition region. J Immunol 130:1856-1862
31. Kubo RT, Sette A, Grey HM, Appella E, Sakaguchi K, Zhu N-Z, Arnott D, Sherman N, Shabanowitz J, Michel H, Bodnar WM, Davis TA, Hunt DF (1994) Definition of specific peptide motifs for four major HLA-A alleles. J Immunol 152:3913-3924
32. Levitsky V, Zhang Q-J, Levitskaya J, Masucci MG (1996) The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J Exp Med 183:915-926
33. Levitsky V, Liu D, Southwood S, Levitskaya J, Sette A, Masucci MG (2000) Supermotif peptide binding and degeneracy of MHC: peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usage. Hum Immunol 61:972-984
34. Li L, Bouvier M (2004) Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue. J Immunol 172:6175-6184
35. Li L, Promadej N, McNicholl JM, Bouvier M (2002) Crystallization and preliminary X-ray crystallographic studies of HLA-A*1101 complexed with an HIV-1 decapeptide. Acta Crystallogr D58:1195-1197
36. Limpakarnjanarat K, Mastro TD, Saisorn S, Uthaivoravit W, Kaewkungwal J, Korattana S, Young NL, Morse SA, Schmid DS, Weniger BG, Nieburg P (1999) HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand. Sex Transm Infect 75:30-35
37. Lin L, Tokunaga K, Ishikawa Y, Bannai M, Kashiwase K, Kuwata S, Akaza T, Tadokoro K, Shibata Y, Juji T (1994) Sequence analysis of serological HLA-A11 split antigens, A11.1 and A11.2. Tissue Antigens 43:78-82
38. Lopez de Castro JA (1989) HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today 10:239-246
39. Madden DR, Gorga JC, Strominger JL, Wiley DC (1992) The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035-1048
40. Maenaka K, Maenaka T, Tomiyama H, Takiguchi M, Stuart DI, Jones EY (2000) Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J Immunol 165:3260-3267
41. Maier R, Falk K, Rotzschke O, Maier B, Gnau V, Stevanovic S, Jung G, Rammensee H-G, Meyerhans A (1994) Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing. Immunogenetics 40:306-308
42. Makhatadze NJ, Sanches-Llamozas P, Franco MT, Layrisse Z (1995) Strong association between major histocompatibility complex class I antigens and immune aberrations among healthy Venezuelans. Hum Immunol 42:189-194
43. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Ferrari C, Chisari FV (1993) HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 177:751-762
44. Moots RJ, Matsui M, Pazmany L, McMichael AJ, Frelinger JA (1991) A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells. Immunogenetics 34:141-148
45. Morrell G, Whalley J, Stewart A, Day S, Lewis L, Makar Y, Fuggle SV, Ross J, Dunn PPJ (1999) Identification of an HLA-A11 serological variant and its characterization by sequencing based typing. Tissue Antigens 53:591-594
46. Palou E, Santos M, Gil J, Campos E, Nogues N, Ribera A (2001) Identification and sequence characterization of a novel HLA-A11 serological variant (HLA-A*1108). Tissue Antigens 57:543-545
47. Paradela A, Garcia-Peydro M, Vazquez J, Rognan D, Lopez de Castro JA (1998) The same natural ligand is involved in allo-recognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity. J Immunol 161:5481-5490
48. Popov I, Dela Cruz CS, Barber BH, Chiu B, Inman RD (2002) Breakdown of CTL tolerance to self HLA-B*2705 induced by exposure to Chlamydia trachomatis. J Immunol 169:4033-4038
49. Pyo CW, Choi H-B, Han H, Hong Y-S, Kim T-G (2001) Identification of HLA-A*11 variant (A*1107) in the Korean population. Tissue Antigens 58:190-192
50. Reynolds SR, Celis E, Sette A, Oratz R, Shapiro RL, Johnston D, Fotino M, Bystryn JC (2000) Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis. J Immunol Methods 244:59-67
51. Robbins PA, Lettice LA, Rota P, Santos-Aguado J, Rothbard J, McMichael AJ, Strominger JL (1989) Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2. J Immunol 143:4098-4103
52. Rotzschke O, Falk K, Stevanovic S, Gnau V, Jung G, Rammensee H-G (1994) Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39:74-77
53. Santos-Aguado J, Barbosa JA, Biro PA, Strominger JL (1988) Molecular characterization of serologic recognition sites in the human HLA-A2 molecule. J Immunol 141:2811-2818
54. Sette A, Sidney J (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201-212
55. Shimojo N, Cowan EP, Engelhard VH, Maloy WL, Coligan JE, Biddison WE (1989) A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73. J Immunol 143:558-564
56. Sidney J, Grey HM, Southwood S, Celis E, Wentworth PA, del Guercio M-F, Kubo RT, Chestnut RW, Sette A (1996) Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol 45:79-93
57. a. Immunity 14:81-92
58. Sriwanthana B, Hodge T, Mastro TD, Dezzutti CS, Bond K, Stephens HAF, Kostrikis LG, Limpakarnjanarat K, Young NL, Qari SH, Lal RB, Chandanayingyong D, McNicholl JM (2001) HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 Δ32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retrovir 17:719-734
59. Steiner NK, Edson SM, Mitton W, Ng J, Hartzman RJ, Hurley CK (2000) Seven novel HLA-A alleles carry previously observed polymorphisms. Tissue Antigens 56:551-552
60. Steiner NK, Rizzo M, Bradshaw D, Baldassarre L, Jones P, Koester R, Ng J, Hartzman RJ, Hurley CK (2003) Seventeen novel HLA-A alleles. Tissue Antigens 62:256-258
61. Sudo T, Kamikawaji N, Kimura A, Date Y, Savoie CJ, Nakashima H, Furuichi E, Kuhara S, Sasazuki T (1995) Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J Immunol 155:4749-4756
62. Takahashi D, Miyazaki T, Araseki M, Sekimoto T, Sato S, Kato T, Ikeda H (2004) Identification of a novel allele HLA-A*1113 in a Japanese donor. Tissue Antigens 64:81-83
63. Takiguchi M, Matsuda T, Tomiyama H, Miwa K (2000a) Analysis of three HLA-A*3303 binding peptide anchors using an HLA-A*3303 stabilization assay. Tissue Antigens 55:296-302
64. Takiguchi M, Matsuda T, Tomiyama H (2000b) Polarity of the P1 anchor residue determines peptide binding specificity between HLA-A*3101 and HLA-A*3303. Tissue Antigens 56:501-506
65. Threlkeld SC, Wentworth PA, Kalams SA, Wilkes BM, Ruhl DJ, Keogh E, Sidney J, Southwood S, Walker BD, Sette A (1997) Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. J Immunol 159:1648-1657
66. Tijssen HJ, Sistermans EA, Van den Beucken M, Krausa P, Joosten I (2000) Complete sequence analysis of the A*1103 allele. Tissue Antigens 55:68-70
67. Tsai S-L, Chen M-H, Yeh C-T, Chu C-M, Lin A-N, Chiou F-H, Chang T-H, Liaw Y-F (1996) Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes. J Clin Invest 97:577-584
68. Tsuchiya K, Kimura A, Kondo M, Nishimura Y, Sasazuki T (2001) Combination of HLA-A and HLA class II alleles controls the susceptibility to rheumatoid arthritis. Tissue Antigens 58:395-401
69. Tussey LG, Matsui M, Rowland-Jones S, Warburton R, Frelinger JA, McMichael A (1994) Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition. J Immunol 152:1213-1221
70. Van der Burg SH, Visseren MJW, Brandt RMP, Kast WM, Melief CJM (1996) Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol 156:3308-3314
71. Wang R-F, Johnston SL, Southwood S, Sette A, Rosenberg SA (1998) Recognition of an antigenic peptide derived from Tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33. J Immunol 160:890-897
72. Wu GG, Cheng L-H, Li Z, Deng Z-H, Zou H-Y, Wei T-L, Zhou D, Li D-C, Gao S-Q, Zhao T-M (2003) Identification of a new HLA allele, A*1114, in a Chinese family. Tissue Antigens 61:253-255
73. Zhang Q-J, Gavioli R, Klein G, Masucci MG (1993) An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc Natl Acad Sci U S A 90:2217-2221